Hyperacute Simultaneous Cardiocerebral Infarction: Rescuing the Brain or the Heart First?

Related Experiment Video

Updated: Feb 16, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.7K

Naruchorn Kijpaisalratana1, Aurauma Chutinet1,2, Nijasri C Suwanwela1,2

  • 1Chulalongkorn Stroke Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.

Frontiers in Neurology
|December 23, 2017
PubMed

Insights

Managing simultaneous acute ischemic stroke and myocardial infarction is challenging. This study proposes a management algorithm for cardiocerebral infarction, emphasizing hemodynamic status and infarct location for treatment decisions.

Area of Science:

  • Cardiology
  • Neurology
  • Emergency Medicine

Background:

  • Concurrent acute ischemic stroke and acute myocardial infarction present a rare but critical medical emergency.
  • Managing these simultaneous conditions poses significant challenges due to the need for timely intervention in both, where treatment for one may impede the other.

Purpose of the Study:

  • To present two cases of hyperacute simultaneous cardiocerebral infarction.
  • To propose a management algorithm for patients experiencing simultaneous cardiocerebral infarction within the thrombolytic window for stroke.

Main Methods:

  • Case report presentation of two patients with simultaneous cardiocerebral infarction.
  • Development of a proposed management algorithm based on hemodynamic status and cerebral infarction site.

Main Results:

  • Illustrative cases of patients presenting with simultaneous cardiocerebral infarction within the 4.5-hour thrombolytic window for stroke.
  • A proposed algorithm to guide clinical decision-making in hyperacute simultaneous cardiocerebral infarction.

Conclusions:

  • Effective management of simultaneous cardiocerebral infarction requires a tailored approach.
  • The proposed algorithm aims to optimize treatment by considering hemodynamic status and the location of cerebral infarction, alongside cardiac monitoring recommendations.

Keywords:
acute ischemic strokeacute myocardial infarctioncardiocerebral infarctioninsular cortexsimultaneous

More Related Videos

Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest07:18

Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest

Published on: April 14, 2023

2.3K
2-Vessel Occlusion/Hypotension: A Rat Model of Global Brain Ischemia09:29

2-Vessel Occlusion/Hypotension: A Rat Model of Global Brain Ischemia

Published on: June 22, 2013

20.7K

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
309
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.1K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
922
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
384
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
294
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
539